Assessment of Hand Grip Strength Using Jamar Dynamometer
To Assess Prevalence of Sarcopenia Using Hand Grip Strength (HGS) as a Marker in Patients With T2DM
1 other identifier
observational
5,000
1 country
1
Brief Summary
Hand grip strength will be measured for all the type 2 diabetic patients. Measurement of maximal grip strength will be performed using Jamar dynamometers, which estimate the muscle strength primarily generated by the flexor muscles of the hand and the forearm. The Jamar displays grip force in both pounds and kilograms, with a maximum of 200 lb (90 kg). It has a peak-hold needle that automatically retains the highest reading until reset. The Jamar test is isometric, with no perceptible motion of the handle, regardless of the grip strength applied. The participants will be encouraged to produce their maximal grip strength. Three trials will be recorded, consisting of a 2-4-second maximal contraction, with a 30-second rest period between each trial. The average of the three readings will be taken.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2023
CompletedFirst Submitted
Initial submission to the registry
July 3, 2023
CompletedFirst Posted
Study publicly available on registry
July 11, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2025
CompletedJuly 11, 2023
July 1, 2023
1.5 years
July 3, 2023
July 10, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Comparison of age and gender specific prevalence of sarcopenia using HGS in patients with T2DM
6 days
Interventions
Hand grip strength as a marker by using JAMAR hand grip dynamometer in patients with T2DM.
Eligibility Criteria
T2DM patient visiting Fortis CDOC Hospital and meeting the Inclusion Criteria will be enrolled in the study.
You may qualify if:
- All patients with Type 2 diabetes of any duration coming for first time in OPD
You may not qualify if:
- Patients with hand fracture
- Thyroid dysfunction
- Any musculoskeletal condition causing difficulty in holding the dynamometer
- Patients with type1 diabetes (T1DM) and gestational diabetes (GDM)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fortis CDOC Hospital
Delhi, 110048, India
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anoop Misra, MD
Fortis CDOC Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
July 3, 2023
First Posted
July 11, 2023
Study Start
July 1, 2023
Primary Completion
December 31, 2024
Study Completion
January 30, 2025
Last Updated
July 11, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will not share